Can-Fite BioPharma Ltd. (TLV:CANF)

Can-Fite BioPharma Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 3, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	59	32	69	120	92	45
Market Cap Growth	17.92%	-53.52%	-42.86%	29.93%	106.23%	-52.27%
Enterprise Value	41	2	30	76	57	28
Last Close Price	0.02	0.03	0.08	0.15	0.20	0.37
PS Ratio	12.02	11.90	24.06	45.20	37.63	6.38
PB Ratio	3.41	1.42	4.36	2.68	4.73	5.31
P/TBV Ratio	6.04	1.42	4.36	2.68	4.73	5.31
EV/Sales Ratio	16.50	0.65	10.63	28.70	23.35	4.00
Debt / Equity Ratio	0.02	0.01	0.01	0.01	0.01	0.03
Asset Turnover	0.08	0.08	0.06	0.06	0.09	0.25
Quick Ratio	2.38	4.42	3.19	7.01	6.57	1.04
Current Ratio	2.93	4.91	3.66	7.35	7.41	2.18
Return on Equity (ROE)	-157.62%	-142.49%	-107.91%	-123.34%	-339.20%	-462.71%
Return on Assets (ROA)	-57.46%	-53.15%	-42.73%	-53.91%	-99.87%	-93.07%
Return on Capital (ROIC)	-102.80%	-94.70%	-66.28%	-77.75%	-204.13%	-271.31%
Earnings Yield	-47.03%	-86.33%	-52.20%	-32.72%	-50.31%	-97.45%
FCF Yield	-47.44%	-95.47%	-55.47%	-25.60%	-42.11%	-85.57%
Buyback Yield / Dilution	-57.39%	-56.71%	-47.49%	-54.31%	-317.19%	-120.84%

Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.